期刊文献+

DNA修复与肿瘤的耐药 被引量:7

Relationship between DNA repair and drug resistance of tumors
原文传递
导出
摘要 化疗药物是临床治疗肿瘤的常见方法,但其先天性和获得性耐药也是临床亟需解决的问题。肿瘤细胞DNA修复能力的改变是引起该类药物产生耐药的重要因素之一。DNA修复是维持基因组稳定的主要因素,一种DNA损伤可能被多种DNA修复通路修复。了解DNA修复与化疗药物耐药性之间的关系,开发DNA修复抑制剂联合化疗可以克服化疗药物的耐药性并提高临床效果,同时为临床合理运用化疗药物及研制低耐药性药物提供理论依据。 chemotherapy is a common treatment for cancer,but its natural and acquired resistance is a serious problem that limits its clinical application.The change of DNA repair ability of cancer cells is one of the reasons which cause resistance to chemotherapeutic agents.DNA repair system is the main factor to maintain the genome stability,usually several repair pathways are involved in the chemotherapeutics efficacy.Therefore,it is important to understand the relationship between DNA repair and chemotherapeutic drug resistance,which can provide the theoretical basis for the clinical use of chemotherapeutic agents and developing new anticancer agents which can overcome the drug resistance.
出处 《生命的化学》 CAS CSCD 2012年第6期526-532,共7页 Chemistry of Life
基金 云南省应用基础研究项目(KKSA201126061) 国家自然科学基金项目(81260501)资助
关键词 DNA修复 耐药性 DNA修复抑制剂 DNA repair drug resistance DNA repair inhibitor
  • 相关文献

参考文献47

  • 1桂贤,刘会敏.肿瘤多药耐药发生机制的研究进展[J].上海医学,2005,28(2):161-164. 被引量:25
  • 2陈玲,李旭.肺癌多药耐药机制及逆转研究[J].实用临床医药杂志,2005,9(11):34-37. 被引量:4
  • 3杨朝阳,陈公琰.肺癌化疗耐药机制的研究进展[J].实用肿瘤学杂志,2005,19(6):465-469. 被引量:6
  • 4Fox M et al. Drug resistance and DNA repair. Cancer Metastasis Rev, 1987,6:261-281.
  • 5Ames BN et al. Endogenous mutagens and the causes of aging and cancer. Mutat Res, 1991, 250: 3-16.
  • 6Moraes MCS et al. DNA repair mechanisms protect our genome from carcinogenesis. Front Biosci, 2012,17: 1362-1388.
  • 7ingJ et al. Emerging cancer therapeutic opportunities target DNA-repair systems. Trends Pharmacol Sci, 2006, 27: 338-344.
  • 8erson SL. Clinical relevance of MGMT in the treatment of cancer.J Clin Oncol, 2002, 20: 2388-2399.
  • 9Pegg AE. Repair ofO(6)-alkylguanine by alkyltransferases. Mutat Res,2000,462: 83-100.
  • 10Gerson SL. MGMT: its role in cancer aetiology and cancer therapeutics. Nat Rev Cancer, 2004, 4: 296-307.

二级参考文献159

  • 1李体远,Jing Jie Yu,Eddie Reed.封闭ERCC1基因表达对卵巢癌细胞耐药的影响[J].中国肿瘤生物治疗杂志,2004,11(2):92-95. 被引量:14
  • 2王彦,吴焕明.肺癌中金属硫蛋白的表达及其与细胞增殖、凋亡的关系[J].中国组织化学与细胞化学杂志,2003,12(4):393-398. 被引量:7
  • 3潘启超,田晖.多种中药单体逆转肿瘤多药耐药性[J].科学通报,1995,40(20):1901-1904. 被引量:69
  • 4黄胜辉,黄志勇.PARP-1:一个肿瘤治疗的新靶点[J].世界华人消化杂志,2006,14(9):841-847. 被引量:11
  • 5GEONGOULIAS V, ARDAVANIS A, TSIAFAKI X, et al. Vinorebine plus cisplatin versus docetaxel plus gemeitabine in advanced non-small-cell lung cancer: a phase Ⅲ randomized tral[ J ]. J Clin Oncol,2005,23 ( 13 ) :2937-2945.
  • 6PUJIL J L, BRETON J L, GERVAIS R, et al versus cisplatin-vinorebine in advanced or metastatic non-small-cell lung cancer. A phase Ⅲ study addressing the case for cisplatin [ J]. Ann Oncol,2005,16(4) :602-610.
  • 7FERRY K V, HAMILTON T C, JOHNSON S W. Increased nucleotide excision repair in cisplatin resistant ovarian cancer cells[J]. Biochem Pharmacol, 2000,60 ( 9 ) : 1305-1313.
  • 8LORD R V N,BRABENDER J,GANDARA D,et al. Low ERCC1 expression correlates with prolonged survival after cisplatin plus gemcitabine chemotherapy in non-small-cell lung cancer[ J ]. Clin Cancer Res ,2002,8 ( 11 ) :2286-2291.
  • 9KENNEDY R D, QUINN J E, MULLAN P B, et al. The role of B RCA1 in the cellular response to chemotherapy [J]. Natl Cancer Inst, 2004,96 ( 22 ) : 1659 -1668.
  • 10DELAATW L, JASPERS N G, HOEIJMAKERS J H. Molecularmechanism of nucleotide excision repair[J]. Genes Dev, 1999, 13 (7) : 768-785.

共引文献80

同被引文献134

引证文献7

二级引证文献52

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部